Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             20 results found
no title author magazine year volume issue page(s) type
1 An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis Dandekar, Devendra S.
2003
52 Suppl 1 p. 59-66
article
2 A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion Leguizamo, Jorge
2003
52 Suppl 1 p. 333-338
article
3 Clinical significance of the expression of estrogen receptors α and β for endocrine therapy of breast cancer Iwase, Hirotaka
2003
52 Suppl 1 p. 34-38
article
4 Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial Niho, Seiji
2003
52 Suppl 1 p. 19-24
article
5 Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells Bouffard, David Y.
2003
52 Suppl 1 p. 497-506
article
6 Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancer Heslin, Martin J.
2003
52 Suppl 1 p. 399-404
article
7 Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma Nakajima, Masahide
2003
52 Suppl 1 p. 319-324
article
8 Induction of TNF-α, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells Niiya, Masami
2003
52 Suppl 1 p. 391-398
article
9 Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms Senderowicz, Adrian M.
2003
52 Suppl 1 p. 61-73
article
10 Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics Yamori, Takao
2003
52 Suppl 1 p. 74-79
article
11 Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors Peters, G. J.
2003
52 Suppl 1 p. 1-12
article
12 Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer Oshita, Fumihiro
2003
52 Suppl 1 p. 73-78
article
13 Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer Yamada, Yasuhide
2003
52 Suppl 1 p. 125-130
article
14 Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer Haddad, Robert I.
2003
52 Suppl 1 p. 303-306
article
15 Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial Santoso, Joseph T.
2003
52 Suppl 1 p. 13-18
article
16 Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1 Ali, Shadan
2003
52 Suppl 1 p. 235-246
article
17 Survival-signaling pathway as a promising target for cancer chemotherapy Fujita, Naoya
2003
52 Suppl 1 p. 24-28
article
18 Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation Peron, Karine
2003
52 Suppl 1 p. 270-276
article
19 The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones Workman, Paul
2003
52 Suppl 1 p. 45-56
article
20 The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine Ostruszka, Leo J.
2003
52 Suppl 1 p. 325-332
article
                             20 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands